Goldbart A et al. (2021) Non-tuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide. BMJ Case Rep. 2021 Oct 28

Asher T. et al (2021) Efficacy and Safety of Inhaled Nitric Oxide for the Treatment of Acute Bronchiolitis: An Evaluation of Three Trials. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Wolak T. et al (2021) Inhaled Nitric Oxide for the Treatment of COVID-19 and Other Viral Pneumonias in Adults. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Confino H. et al (2020) Nitric Oxide Tumor Ablation Stimulates an Anti-Tumor Immune Response in Mice. American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy, October 19-20, 2020.

Goldshtein M. et al (2020). Nitric Oxide is a Powerful Anti-Coronavirus Inhaled Agent that Acts Within Hours. CHEST Annual Meeting, October 18-21, 2020.

Goldbart A. et al (2020). Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently via Inhalation to Subjects with Bronchiolitis – a Multi-Center Double Blind Study. CHEST Annual Meeting, October 18-21, 2020.

Confino H. et al (2020). Nitric Oxide Lung Cancer Active Vaccination. 2020 North American Conference on Lung Cancer, October 16th.

Confino H. et.al (2020). Gaseous Nitric Oxide at high concentration is a powerful anti-tumor agent in-vitro and in-vivo. American Association for Cancer Research Virtual Annual Meeting II, June 22nd.

Goldbart A. et al (2020). Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial. Scientific Reports (Nature), June 15th.

Szymanski, H. (2019). Risks and A Better Solution for Cylinder-Free Nitric Oxide Delivery. MedTech Intelligence, October 2019.

• 1
• 2
• 3
• 4
• Next »